Literature DB >> 21143446

Plasma lipid disturbances and cognitive decline.

Vincenza Frisardi, Francesco Panza, Vincenzo Solfrizzi, Davide Seripa, Alberto Pilotto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21143446     DOI： 10.1111/j.1532-5415.2010.03164.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  6 in total

1.  Lipid metabolic dysregulation is involved in Parkinson's disease dementia.

Authors:  Mei-Xue Dong; You-Dong Wei; Ling Hu
Journal:  Metab Brain Dis       Date:  2021-01-12       Impact factor: 3.584

2.  Characterization of a normal control group: are they healthy?

Authors:  C J Aine; L Sanfratello; J C Adair; J E Knoefel; C Qualls; S L Lundy; A Caprihan; D Stone; J M Stephen
Journal:  Neuroimage       Date:  2013-09-20       Impact factor: 6.556

Review 3.  Nutraceuticals against Neurodegeneration: A Mechanistic Insight.

Authors:  Vivekkumar P Dadhania; Priyanka P Trivedi; Ajit Vikram; Durga Nand Tripathi
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

4.  Role of Liver X Receptor in AD Pathophysiology.

Authors:  Adrián G Sandoval-Hernández; Luna Buitrago; Herman Moreno; Gloria Patricia Cardona-Gómez; Gonzalo Arboleda
Journal:  PLoS One       Date:  2015-12-31       Impact factor: 3.240

Review 5.  Nutraceuticals in Neurological Disorders.

Authors:  Rashita Makkar; Tapan Behl; Simona Bungau; Gokhan Zengin; Vineet Mehta; Arun Kumar; Md Sahab Uddin; Ghulam Md Ashraf; Mohamed M Abdel-Daim; Sandeep Arora; Roxana Oancea
Journal:  Int J Mol Sci       Date:  2020-06-22       Impact factor: 5.923

Review 6.  Nutraceuticals in cognitive impairment and Alzheimer's disease.

Authors:  P Mecocci; C Tinarelli; R J Schulz; M C Polidori
Journal:  Front Pharmacol       Date:  2014-06-23       Impact factor: 5.810
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.